HCPCS Level IIdrugActive
J9226
Supprelin la implant
BETOS: O1D
Effective: 2024-01-01
Referenced in 1 policies
Description
Histrelin implant (supprelin la), 50 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Supprelin LA implant
Manufacturer
Endo USA, Inc.
HCPCS Dosage
50 MG
Billing Units
1.0000
1
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.